Berapakah harga Infinity Pharmaceuticals, Inc. (INFI)

Harga Infinity Pharmaceuticals, Inc. (INFI) adalah $0.0039

Apakah topi pasaran Infinity Pharmaceuticals, Inc. (INFI)

Cap pasaran Infinity Pharmaceuticals, Inc. (INFI) adalah $235.97K

Infinity Pharmaceuticals, Inc. (INFI) Pecahan Saham

Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme. IPI-549 is undergoing Phase 2 trials for metastatic triple negative breast cancer and urothelial cancer, and Phase 1/1b trials for various solid tumors. The company maintains several strategic partnerships: with Intellikine, Inc. for the discovery, development, and commercialization of PI3K delta and/or gamma isoform-targeting pharmaceuticals; with Verastem, Inc. for the research, development, commercialization, and production of duvelisib and related compounds; and with PellePharm, Inc. to advance and commercialize its hedgehog inhibitor program, IPI-926, which is also a clinical-stage investigational drug. Furthermore, Infinity Pharmaceuticals holds collaborative agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company.

Tahun	Pecahan	Gandaan	Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Pecahan

Gandaan

Gandaan Kumulatif

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Bilangan pecahan saham	Gandaan Kumulatif	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Syarikat

Bilangan pecahan saham

Gandaan Kumulatif

Negara